Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults

Trial Profile

Clofarabine added to prephase and consolidation therapy in acute lymphoblastic leukemia in adults

Active, no longer recruiting
Phase of Trial: Phase II/III

Latest Information Update: 12 Dec 2017

At a glance

  • Drugs Clofarabine (Primary) ; Antineoplastics
  • Indications Acute lymphoblastic leukaemia
  • Focus Adverse reactions; Therapeutic Use
  • Acronyms EORTC 06083; HOVON 100 ALL
  • Most Recent Events

    • 12 Dec 2017 Status changed to active, no longer recruiting as per results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
    • 12 Dec 2017 Results presented at the 59th Annual Meeting and Exposition of the American Society of Hematology
    • 26 Jan 2013 Planned number of patients changed from 340 to 376 as reported by European Clinical Trials Database record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top